Biocon

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE376G01013
  • NSEID: BIOCON
  • BSEID: 532523
INR
385.00
5 (1.32%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 79.93 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 201791,
    "name": "Biocon",
    "stock_name": "Biocon",
    "full_name": "Biocon Ltd.",
    "name_url": "stocks-analysis/biocon",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "385.00",
    "chg": 5,
    "chgp": "1.32%",
    "dir": 1,
    "prev_price": "380.00",
    "mcapval": "62,124.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532523,
    "symbol": "BIOCON",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE376G01013",
    "curr_date": "Sep 18, 03:30 PM",
    "curr_time": "12:31 PM",
    "last_traded_at": "Sep 18, 03:30 PM IST",
    "bse_nse_vol": "79.93 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 18, 2026",
    "traded_date_str": "2026 09 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biocon-201791-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Biocon Ltd. Downgraded to Sell Amid Technical and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-downgraded-to-sell-amid-technical-and-financial-concerns-4194441",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BioconLtd_mojoScore_4194441.png",
        "date": "2026-09-16 08:22:38",
        "description": "Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 15 Sep 2026. This shift reflects a combination of deteriorating technical indicators, flat financial performance, and valuation concerns, despite some long-term strengths. The company’s current Mojo Score stands at 48.0, with a mid-cap market capitalisation, signalling caution for investors amid recent market volatility."
      },
      {
        "title": "Biocon Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-technical-momentum-shifts-amid-mixed-market-signals-4193949",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BioconLtd_technicaldot_4193949.png",
        "date": "2026-09-16 08:01:23",
        "description": "Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. The stock’s recent downgrade from Hold to Sell by MarketsMOJO, coupled with a 2.55% decline in daily price, underscores growing investor caution amid sideways price action and mixed technical indicators."
      },
      {
        "title": "Biocon Ltd Declines 1.59% Despite Derivatives Surge: 2 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-declines-159-despite-derivatives-surge-2-key-factors-driving-the-week-4191777",
        "imagepath": "",
        "date": "2026-09-12 17:06:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>7 Sep:</strong> Stock opens at Rs.393.50, declines 0.94%</p>\n                    <p><strong>8 Sep:</strong> Minor dip to Rs.392.55 (-0.24%) on lower volume</p>\n                    <p><strong>9 Sep:</strong> Surge in call option activity and open interest; stock gains 0.62% to Rs.395.00</p>\n                    <p><strong>10 Sep:</strong> Price retreats to Rs.390.00 (-1.27%) amid mixed technical signals</p>\n                    <p><strong>11 Sep:</strong> Slight recovery to Rs.390.95 (+0.24%) closes the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.3..."
      },
      {
        "title": "Biocon Ltd. Sees Sharp Open Interest Surge Amidst Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-sharp-open-interest-surge-amidst-mixed-technical-signals-4188318",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BioconLtd_oi_spurts_by_underlying_4188318.png",
        "date": "2026-09-09 15:00:08",
        "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 17.0% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and potential shifts in investor positioning. Despite a modest 0.97% day gain and outperforming its sector by 2.01%, the stock’s mixed technical indicators and falling delivery volumes suggest a nuanced outlook for traders and investors alike."
      },
      {
        "title": "Biocon Ltd Sees Significant Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-significant-open-interest-surge-amid-mixed-technical-signals-4188268",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BioconLtd_oi_spurts_by_underlying_4188268.png",
        "date": "2026-09-09 14:00:05",
        "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 15.3% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. This development comes alongside a modest 1.26% price gain and outperformance relative to its sector, prompting a closer examination of volume patterns, market sentiment, and potential directional bets."
      },
      {
        "title": "Biocon Ltd Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-significant-open-interest-surge-amid-mixed-market-signals-4188234",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BioconLtd_oi_spurts_by_underlying_4188234.png",
        "date": "2026-09-09 13:00:07",
        "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 15.2% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 1.13% gain in the stock price, the underlying dynamics suggest a complex interplay of directional bets and liquidity flows that merit close attention from investors and analysts alike."
      },
      {
        "title": "Biocon Ltd Sees Significant Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-significant-open-interest-surge-amid-mixed-technical-signals-4188214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BioconLtd_oi_spurts_by_underlying_4188214.png",
        "date": "2026-09-09 12:00:07",
        "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 14.57% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest 0.79% price gain on 9 September 2026, the stock outperformed its sector by 1.74%, reflecting nuanced market dynamics that merit close analysis."
      },
      {
        "title": "Biocon Ltd. Sees Significant Open Interest Surge Amidst Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-significant-open-interest-surge-amidst-mixed-market-signals-4188132",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BioconLtd_oi_spurts_by_underlying_4188132.png",
        "date": "2026-09-09 11:00:08",
        "description": "Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.26% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 1.63% gain in the stock price, the underlying dynamics suggest a complex interplay of bullish and cautious bets as the company navigates sectoral headwinds and broader market volatility."
      },
      {
        "title": "Rs 400 Calls on Biocon Ltd. See Heavy Activity — What the Strike Price Tells You",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-surge-in-call-option-activity-amid-bullish-sentiment-4187674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BioconLtd_most_active_stocks_calls_4187674.png",
        "date": "2026-09-09 10:00:07",
        "description": "6,847 call contracts at the Rs 400 strike traded on Biocon Ltd. on 9 Sep 2026, with the stock closing at Rs 400.40. This near-exact alignment between strike and underlying price highlights a focused directional wager, supported by a 1.16% gain in the cash market and a two-day rally streak."
      }
    ],
    "total": 5883,
    "sid": "201791",
    "stock_news_url": "https://www.marketsmojo.com/news/biocon-201791"
  },
  "announcements": [
    {
      "caption": "Communication Regarding Remittance Of Final Dividend For The FY 2025-26",
      "datetime": "09-Sep-2026",
      "details": "Communication regarding remittance of final dividend for the FY 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "08-Sep-2026",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Sep-2026",
      "details": "Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has declared <strong>10%</strong> dividend, ex-date: 03 Jul 26",
          "dt": "2026-07-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Biocon Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 12 Jun 19",
          "dt": "2019-06-12",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Biocon Ltd Declines 1.59% Despite Derivatives Surge: 2 Key Factors Driving the Week

2026-09-12 17:06:55

Key Events This Week

7 Sep: Stock opens at Rs.393.50, declines 0.94%

8 Sep: Minor dip to Rs.392.55 (-0.24%) on lower volume

9 Sep: Surge in call option activity and open interest; stock gains 0.62% to Rs.395.00

10 Sep: Price retreats to Rs.390.00 (-1.27%) amid mixed technical signals

11 Sep: Slight recovery to Rs.390.95 (+0.24%) closes the week

stock-recommendationAnnouncement

Communication Regarding Remittance Of Final Dividend For The FY 2025-26

09-Sep-2026 | Source : BSE

Communication regarding remittance of final dividend for the FY 2025-26

Announcement under Regulation 30 (LODR)-Press Release / Media Release

08-Sep-2026 | Source : BSE

Press Release

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

08-Sep-2026 | Source : BSE

Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Biocon Ltd. has declared 10% dividend, ex-date: 03 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Biocon Ltd. has announced 1:1 bonus issue, ex-date: 12 Jun 19

stock-summary
RIGHTS

No Rights history available